David Jang, MD
Otolaryngology · Durham, NCNPI 1295995355
Payments from drug & device makers
Across 1,757 payments — averaging $592.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$481K
- Regeneron Healthcare Solutions, Inc.$266K
- Regeneron$243K
- Sanofi$35K
- Medtronic$14K
- Stryker$2K
- plus $967 from 6 others
Across 15 payments — averaging $678.10 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$10K
What the payments were for
- Consulting fees$33,77610%
- Speaking & faculty fees$242,79975%
- Travel & lodging$38,60612%
- Food & beverage$9,0123%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 8 | $481,365 |
| Regeneron Healthcare Solutions, Inc. | 266 | $265,698 |
| Regeneron | 1,377 | $243,006 |
| Sanofi | 26 | $35,041 |
| Medtronic(2 entities) | 54 | $13,835 |
| Stryker | 17 | $1,787 |
| Aerin Medical Inc. | 2 | $313 |
| Intersect ENT, Inc. | 3 | $205 |
| GSK | 1 | $125 |
| AstraZeneca | 1 | $122 |
| Acclarent, Inc | 1 | $119 |
| Acera Surgical, Inc. | 1 | $84 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$270,610
- FUSION$9,037
- STEALTHSTATION S8 PLATFORM$1,392
- SCOPIS ENT$662
- NSE - HIGH SPEED DRILLS$480
- VIVAER STYLUS$313
- RHINAER STYLUS$313
- XPRESS ENT DILATION SYSTEM$168
- PROPEL$137
- N/A$131
- UNIVERSAL NEURO 3$126
- NUCALA$125
- TEZSPIRE$122
- TruDi Nav Cable$119
- NUVENT$102
How this compares
$1,041,699 in reported general payments places this provider in the 95th percentile of 362 otolaryngology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 65 | $2,065 |
| Azelastine Hcl | 29 | $548 |
| Fluticasone Propionate | 26 | $503 |
| Doxycycline Monohydrate | 24 | $373 |
| Cyproheptadine Hcl | 14 | $89 |
| Prednisone | 16 | $72 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Durham
- David WitsellDurham$80K
- Howard FrancisDurham$38K
- Eileen RaynorDurham$25K
- Ralph Abi HachemDurham$9K
- David KaylieDurham$8K
- Feras AckallDurham$7K
- Seth CohenDurham$6K
- Robert FerrisRaleigh$2.5M
- Mark WeigelHuntersville$275K
- Stephen PottsWinston Salem$242K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.